Reviewed,
UniProtKB/Swiss-Prot Q64364 (CD2A2_MOUSE)
Last modified
December 15, 2009.
Version 74.
History...
Clusters with 100%,
90%,
50% identity |
Documents (2) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Cyclin-dependent kinase inhibitor 2A, isoform 3 Alternative name(s): p19ARF | ||
| Gene names |
| ||
| Organism | Mus musculus (Mouse) | ||
| Taxonomic identifier | 10090 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus |
Protein attributes
| Sequence length | 169 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Capable of inducing cell cycle arrest in G1 and G2 phases. Acts as a tumor suppressor. Binds to MDM2 and blocks its nucleocytoplasmic shuttling by sequestering it in the nucleolus. This inhibits the oncogenic action of MDM2 by blocking MDM2-induced degradation of p53 and enhancing p53-dependent transactivation and apoptosis. Also induces G2 arrest and apoptosis in a p53-independent manner by preventing the activation of cyclin B1/CDC2 complexes. Binds to BCL6 and down-regulates BCL6-induced transcriptional repression. Binds to E2F1 and MYC and blocks their transcriptional activator activity but has no effect on MYC transcriptional repression. Binds to TOP1/TOPOI and stimulates its activity. This complex binds to rRNA gene promoters and may play a role in rRNA transcription and/or maturation. Interacts with NPM1/B23 and promotes its polyubiquitination and degradation, thus inhibiting rRNA processing. Interacts with UBE2I/UBC9 and enhances sumoylation of a number of its binding partners including MDM2 and E2F1. Binds to HUWE1 and represses its ubiquitin ligase activity. May play a role in controlling cell proliferation and apoptosis during mammary gland development. Ref.1 Ref.6 Ref.8 Ref.9 Ref.13 Ref.14 Ref.15 Ref.16 Ref.12 UniProtKB Q8N726 |
| Subunit structure | Does not interact with cyclins, CDC2, CDK2, CDK4, CDK5 or CDK6. Binds to BCL6, E2F1, HUWE1, MDM2, MYC, NPM1/B23, TOP1/TOPOI and UBE2I/UBC9. Interacts with TBRG1. Interacts with CDKN2AIP and E4F1. Ref.8 Ref.13 Ref.14 Ref.11 Ref.17 UniProtKB Q8N726 |
| Subcellular location | |
| Developmental stage | Not detected in 12-week virgin mammary glands. Expression increases (at protein level) six-fold during pregnancy and remains at this level during lactation. During involution, a slight increase is observed at days 2 and 8 followed by a sharp decline at day 15. Ref.12 |
| Induction | By progesterone. Induced by activated Ras, and this requires DMTF1. Repressed by non-classical inhibitors of NF-kappa-B signaling such as doxorubicin, daunorubicin and UVC, and by the NF-kappa-B p65 subunit (RELA). Ref.15 Ref.12 Ref.10 Ref.18 |
| Disruption phenotype | Mice lacking isoform p19ARF of Cdkn2a display delayed mammary gland involution. Ref.12 |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| Pex19 | Q8VCI5 | 1 | EBI-1202306,EBI-1810767 | |
| Ppp1ca | P62137 | 1 | EBI-1202287,EBI-357187 | |
| Ppp1cc | P63087-1 | 1 | EBI-1202287,EBI-450267 |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] Note: Isoform 1 and isoform 3 arise due to the use of two alternative first exons joined to a common exon 2 at the same acceptor site but in different reading frames, resulting in two completely different isoforms. | ||||||
| Isoform 3 Ref.1 (identifier: Q64364-1) Also known as: p19ARF; ARF; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 1 (identifier: P51480-1) Also known as: p16INK4a; The sequence of this isoform can be found in the external entry P51480-1. Isoforms of the same protein are often annotated in two different entries if their sequences differ significantly. | ||||||
| Isoform 2 (identifier: P51480-2) The sequence of this isoform can be found in the external entry P51480-2. Isoforms of the same protein are often annotated in two different entries if their sequences differ significantly. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||
Molecule processing | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 169 | 169 | Cyclin-dependent kinase inhibitor 2A, isoform 3 | PRO_0000144182 | |||||||||
Regions | |||||||||||||
| Compositional bias | 3 – 168 | 166 | Arg-rich | ||||||||||
Experimental info | |||||||||||||
| Mutagenesis | 85 | 1 | L → P or R: No effect on activity. Ref.7 | ||||||||||
| Mutagenesis | 93 | 1 | P → S: No effect on activity. Ref.7 | ||||||||||
| Mutagenesis | 97 | 1 | R → Q: No effect on activity. Ref.7 | ||||||||||
| Mutagenesis | 105 – 106 | 2 | Missing: No effect on activity. Ref.7 | ||||||||||
| Mutagenesis | 120 | 1 | A → T: No effect on activity. Ref.7 | ||||||||||
Secondary structure | |||||||||||||
Helix Strand Turn | |||||||||||||
| Helix | 4 – 14 | 11 | |||||||||||
| Helix | 20 – 29 | 10 | |||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest." Quelle D.E., Zindy F., Ashmun R.A., Sherr C.J. Cell 83:993-1000(1995) [PubMed: 8521522] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION. |
| [2] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Strain: NMRI. Tissue: Mammary tumor. |
| [3] | "Characterization of the murine p19ARF promoter CpG island and its methylation pattern in primary lymphomas." Melendez B., Malumbres M., de Castro I.P., Santos J., Pellicer A., Fernandez-Piqueras J. Carcinogenesis 21:817-821(2000) [PubMed: 10753221] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-64. Strain: 129/SvJ. |
| [4] | "Sequence variation and chromosomal mapping of the murine Cdkn2a tumor suppressor gene." Herzog C.R., You M. Mamm. Genome 8:65-66(1997) [PubMed: 9021155] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-63. Strain: 020, 129/J, A/J, A/Wy, AKR/J, B10.A, B10.D2(58N), BALB/c, C3H/21BG, C3H/HeJ, C57BL/10SCN, C57BL/10SN, C57BL/6By, C57BL/6J, C57BR/cdJ, CBA/J, DBA/2J, HS/IBG, LP/J, LS/IBG, MA/M4J, PL/J, RF/J, Sencar, SJL/J, SM/J, ST/J and SWR/J. Tissue: Lung. |
| [5] | "Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1." Inoue K., Roussel M.F., Sherr C.J. Proc. Natl. Acad. Sci. U.S.A. 96:3993-3998(1999) [PubMed: 10097151] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-63. Strain: 129/SvjE. |
| [6] | "Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF." Kamijo T., Zindy F., Roussel M.F., Quelle D.E., Downing J.R., Ashmun R.A., Grosveld G., Sherr C.J. Cell 91:649-659(1997) [PubMed: 9393858] [Abstract] Cited for: FUNCTION. |
| [7] | "Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF." Quelle D.E., Cheng M., Ashmun R.A., Sherr C.J. Proc. Natl. Acad. Sci. U.S.A. 94:669-673(1997) [PubMed: 9012842] [Abstract] Cited for: MUTAGENESIS OF LEU-85; PRO-93; ARG-97; 105-GLY-HIS-106 AND ALA-120. |
| [8] | "The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53." Pomerantz J., Schreiber-Agus N., Liegeois N.J., Silverman A., Alland L., Chin L., Potes J., Chen K., Orlow I., Lee H.-W., Cordon-Cardo C., DePinho R.A. Cell 92:713-723(1998) [PubMed: 9529248] [Abstract] Cited for: FUNCTION, INTERACTION WITH MDM2. |
| [9] | "P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2." Tao W., Levine A.J. Proc. Natl. Acad. Sci. U.S.A. 96:6937-6941(1999) [PubMed: 10359817] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION. |
| [10] | "Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis." Inoue K., Wen R., Rehg J.E., Adachi M., Cleveland J.L., Roussel M.F., Sherr C.J. Genes Dev. 14:1797-1809(2000) [PubMed: 10898794] [Abstract] Cited for: INDUCTION. |
| [11] | "CARF is a novel protein that cooperates with mouse p19ARF (human p14ARF) in activating p53." Hasan M.K., Yaguchi T., Sugihara T., Kumar P.K.R., Taira K., Reddel R.R., Kaul S.C., Wadhwa R. J. Biol. Chem. 277:37765-37770(2002) [PubMed: 12154087] [Abstract] Cited for: INTERACTION WITH CDKN2AIP. |
| [12] | "p19ARF determines the balance between normal cell proliferation rate and apoptosis during mammary gland development." Yi Y., Shepard A., Kittrell F., Mulac-Jericevic B., Medina D., Said T.K. Mol. Biol. Cell 15:2302-2311(2004) [PubMed: 15105443] [Abstract] Cited for: DEVELOPMENTAL STAGE, INDUCTION, DISRUPTION PHENOTYPE. |
| [13] | "p19ARF directly and differentially controls the functions of c-Myc independently of p53." Qi Y., Gregory M.A., Li Z., Brousal J.P., West K., Hann S.R. Nature 431:712-717(2004) [PubMed: 15361884] [Abstract] Cited for: FUNCTION, INTERACTION WITH MYC. |
| [14] | "The ARF tumor suppressor inhibits BCL6-mediated transcriptional repression." Suzuki H., Kurita M., Mizumoto K., Moriyama M., Aiso S., Nishimoto I., Matsuoka M. Biochem. Biophys. Res. Commun. 326:242-248(2005) [PubMed: 15567177] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH BCL6. |
| [15] | "Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor." Sreeramaneni R., Chaudhry A., McMahon M., Sherr C.J., Inoue K. Mol. Cell. Biol. 25:220-232(2005) [PubMed: 15601844] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, INDUCTION. |
| [16] | "Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer." Mallakin A., Sugiyama T., Taneja P., Matise L.A., Frazier D.P., Choudhary M., Hawkins G.A., D'Agostino R.B. Jr., Willingham M.C., Inoue K. Cancer Cell 12:381-394(2007) [PubMed: 17936562] [Abstract] Cited for: FUNCTION. |
| [17] | "A novel nuclear interactor of ARF and MDM2 (NIAM) that maintains chromosomal stability." Tompkins V.S., Hagen J., Frazier A.A., Lushnikova T., Fitzgerald M.P., di Tommaso A.D., Ladeveze V., Domann F.E., Eischen C.M., Quelle D.E. J. Biol. Chem. 282:1322-1333(2007) [PubMed: 17110379] [Abstract] Cited for: INTERACTION WITH TBRG1. |
| [18] | "Repression of Dmp1 and Arf transcription by anthracyclins: critical roles of the NF-kappaB subunit p65." Taneja P., Mallakin A., Matise L.A., Frazier D.P., Choudhary M., Inoue K. Oncogene 26:7457-7466(2007) [PubMed: 17546045] [Abstract] Cited for: INDUCTION. |
| [19] | "Solution structure of the p53 regulatory domain of the p19Arf tumor suppressor protein." DiGiammarino E.L., Filippov I., Weber J.D., Bothner B., Kriwacki R.W. Biochemistry 40:2379-2386(2001) [PubMed: 11327858] [Abstract] Cited for: STRUCTURE BY NMR OF 1-37. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | L76092 mRNA. Translation: AAC42080.1. BC058190 mRNA. Translation: AAH58190.3. S80650 mRNA. Translation: AAB35770.1. AJ238890 Genomic DNA. Translation: CAB65598.1. U49281 Genomic DNA. Translation: AAC00053.1. U49282 Genomic DNA. Translation: AAC00054.1. AF120108 Genomic DNA. Translation: AAD33245.1. | ||||||||||||
| IPI | IPI00133446. | ||||||||||||
| RefSeq | NP_034007.1. | ||||||||||||
| UniGene | Mm.4733 | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| DisProt | DP00335. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-24169N. | ||||||||||||
| IntAct | Q64364. 4 interactions. | ||||||||||||
| STRING | Q64364. | ||||||||||||
Proteomic databases | |||||||||||||
| PRIDE | Q64364. | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENSMUST00000030237; ENSMUSP00000030237; ENSMUSG00000044303; Mus musculus. [Genome view] | ||||||||||||
| GeneID | 12578. | ||||||||||||
| UCSC | uc008toi.1. mouse. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 12578. | ||||||||||||
| MGI | MGI:104738. Cdkn2a. | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOVERGEN | Q64364. | ||||||||||||
| InParanoid | Q64364. | ||||||||||||
| OrthoDB | EOG9N5ZK9. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q64364. | ||||||||||||
| Bgee | Q64364. | ||||||||||||
| CleanEx | MM_CDKN2A. | ||||||||||||
| Genevestigator | Q64364. | ||||||||||||
| GermOnline | ENSMUSG00000044303. Mus musculus. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR010868. P19Arf_N. [Graphical view] | ||||||||||||
| PANTHER | PTHR21414. P19Arf_N. 1 hit. | ||||||||||||
| Pfam | PF07392. P19Arf_N. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other Resources | |||||||||||||
| NextBio | 281698. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | CD2A2_MOUSE | ||||||||
| Accession | Primary (citable) accession number: Q64364 Secondary accession number(s): Q4U255, Q9QXC7, Q9R051 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |

Clusters with


